Zacks Research Issues Negative Estimate for CLB Earnings

Core Laboratories Inc. (NYSE:CLB) – Analysts at Zacks Research decreased their Q3 2026 EPS estimates for shares of Core Laboratories in a research note issued to investors on Tuesday, July 8th. Zacks Research analyst R. Department now anticipates that the oil and gas company will post earnings per share of $0.16 for the quarter, down from their prior forecast of $0.19. The consensus estimate for Core Laboratories’ current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories’ Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $0.79 EPS and Q1 2027 earnings at $0.20 EPS.

Core Laboratories (NYSE:CLB) last released its earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The company had revenue of $123.59 million during the quarter, compared to analysts’ expectations of $125.09 million. During the same period in the prior year, the company posted $0.19 earnings per share. The company’s revenue was down 4.7% on a year-over-year basis.

A number of other brokerages also recently issued reports on CLB. Citigroup lowered their price target on Core Laboratories from $16.00 to $13.00 and set a “neutral” rating on the stock in a report on Tuesday, May 13th. Stifel Nicolaus reduced their price objective on Core Laboratories from $19.00 to $15.00 and set a “hold” rating for the company in a research report on Tuesday, April 15th. Finally, Wall Street Zen cut Core Laboratories from a “hold” rating to a “sell” rating in a research report on Friday, April 25th. Two analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, Core Laboratories presently has an average rating of “Hold” and an average price target of $15.00.

Core Laboratories Stock Up 2.8%

NYSE:CLB opened at $12.92 on Thursday. Core Laboratories has a fifty-two week low of $10.14 and a fifty-two week high of $25.13. The firm has a market cap of $605.69 million, a P/E ratio of 21.90, a P/E/G ratio of 3.87 and a beta of 1.41. The firm has a 50-day simple moving average of $11.81 and a two-hundred day simple moving average of $14.32. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21.

Institutional Investors Weigh In On Core Laboratories

Hedge funds and other institutional investors have recently made changes to their positions in the company. Assetmark Inc. purchased a new position in Core Laboratories during the 4th quarter valued at $26,000. Smartleaf Asset Management LLC grew its holdings in shares of Core Laboratories by 173.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,037 shares of the oil and gas company’s stock worth $35,000 after purchasing an additional 1,293 shares during the last quarter. AlphaQuest LLC increased its position in shares of Core Laboratories by 265,800.0% during the first quarter. AlphaQuest LLC now owns 2,659 shares of the oil and gas company’s stock worth $40,000 after acquiring an additional 2,658 shares during the period. Tower Research Capital LLC TRC increased its position in shares of Core Laboratories by 843.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 3,284 shares of the oil and gas company’s stock worth $57,000 after acquiring an additional 2,936 shares during the period. Finally, BNP Paribas Financial Markets purchased a new position in shares of Core Laboratories during the fourth quarter worth approximately $123,000. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were given a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.31%. The ex-dividend date was Monday, May 5th. Core Laboratories’s dividend payout ratio is currently 6.78%.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.